Browsing by Subject "TAFI"
Now showing items 1-3 of 3
-
Presence of thrombophilia and levels of coagulation factors, coagulation inhibitors and TAFI do not affect global haemostasis or bleeding phenotype in patients with haemophilia A
(Pergamon-Elsevier Science Ltd, Oxford, 2019) -
Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia
(Pergamon-Elsevier Science Ltd, Oxford, 2009) -
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): A Molecular Link Between Coagulation and Fibrinolysis
(Srpsko lekarsko društvo, Beograd, 2010)